Sabby Management’s Acura Pharmaceuticals ACUR Stock Holding History

Sabby Management’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-103,444	Closed	-$79K	–	366
2016 Q4	$79K	Sell	103,444 -249,391	-71%	-$261K	﹤0.01%	273
2016 Q3	$565K	Sell	352,835 -165,609	-32%	-$293K	0.02%	215
2016 Q2	$959K	Sell	518,444 -130,440	-20%	-$337K	0.05%	164
2016 Q1	$1.84M	Sell	648,884 -78,981	-11%	-$168K	0.09%	107
2015 Q4	$1.84M	Sell	727,865 -15,738	-2%	-$38.3K	0.1%	131
2015 Q3	$1.75M	Buy	+743,603	New	+$2.53M	0.07%	174

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Sabby Management's ACUR Position: Q1 2017 in Review

Sabby Management sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 103,444 shares — an estimated $79K sold.

Sabby Management first reported a position in ACUR in Q3 2015 and held it in 6 quarters. The position peaked at $1.84M in Q4 2015. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

Sabby Management reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Sabby Management sold 103,444 Acura Pharmaceuticals shares in Q1 2017, an estimated $79K.
Sabby Management first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 6 quarters.
Sabby Management's Acura Pharmaceuticals position peaked at $1.84M in Q4 2015.
3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.